Form 4: Nuvalent Director Matthew Shair Executes Stock Sales Under 10b5-1 Plan

Director Matthew Shair sold shares of Nuvalent, Inc. (NUVL) under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On April 1, 2024, Matthew Shair, a director of Nuvalent, Inc., sold shares of Class A Common Stock.
• The sales were executed under a Rule 10b5-1 trading plan adopted on December 21, 2023.
• A total of 37,500 shares were sold in multiple transactions at weighted average prices of $76.82 and $77.19.
• Following the reported transactions, Shair directly owns 1,649,698 shares of Class A Common Stock.
• Additionally, 238,522 shares are held indirectly through the Matthew D. Shair 2021 Irrevocable Family Trust, over which Shair has voting and dispositive power.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing relates to routine stock sales under a pre-arranged trading plan. It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Risks

• Sales by insiders, even under 10b5-1 plans, can sometimes be perceived negatively by the market.

Future Outlook

The filing does not contain any forward-looking statements regarding the company's future performance.

Industry Context

Insider transactions are routinely monitored by investors as they can provide insights into management's perspective on the company's valuation and future prospects. Sales under 10b5-1 plans are less indicative of immediate sentiment as they are pre-arranged.

Stakeholder Impact

• The stock sale could have a minor impact on shareholders if it creates downward pressure on the stock price, although sales under 10b5-1 plans are usually anticipated.

Key Dates